The Hedgehog (Hh) signaling pathway plays critical roles in metazoan development and in cancer. How the Hh ligand is secreted and spreads to distant cells is unclear, given its covalent modification with a hydrophobic cholesterol molecule, which makes it stick to membranes. We demonstrate that Hh ligand secretion from vertebrate cells is accomplished via two distinct and synergistic cholesteroldependent binding events, mediated by two proteins that are essential for vertebrate Hh signaling: the membrane protein Dispatched (Disp) and a member of the Scube family of secreted proteins. Cholesterol modification is sufficient for a heterologous protein to interact with Scube and to be secreted in a Scube-dependent manner. Disp and Scube recognize different structural aspects of cholesterol similarly to how Niemann-Pick disease proteins 1 and 2 interact with cholesterol, suggesting a hand-off mechanism for transferring Hh from Disp to Scube. Thus, Disp and Scube cooperate to dramatically enhance the secretion and solubility of the cholesterol-modified Hh ligand.
INTRODUCTION
The Hedgehog (Hh) signaling pathway has fundamental roles in embryonic development, adult stem cell maintenance, and carcinogenesis (Lum and Beachy, 2004) . Hh signaling is triggered by binding of the secreted Hh ligand to its membrane receptor, Patched (Ptch), setting in motion signal transduction events that ultimately lead to the specific transcriptional output of the Hh pathway. The Hh ligand is generated from a precursor protein that is translocated into the endoplasmic reticulum (ER), undergoes signal sequence cleavage, and is then modified covalently with two lipids: (1) a palmityl residue is attached at the N terminus by the palmityl transferase Skinny hedgehog (Chamoun et al., 2001) , and (2) a cholesteryl residue is attached at the C terminus by autocatalytic modification (Porter et al., 1996) . The cholesterol modification reaction relies on the intein activity of the C-terminal domain of the Hh precursor, and generates an N-terminal fragment (the cholesterol-modified Hh ligand) and a C-terminal fragment that is disposed of by ER-associated degradation (Chen et al., 2011) . The two lipid modifications of the Hh ligand occur independently (Chamoun et al., 2001) and are both essential for normal Hh signaling (Chamoun et al., 2001; Traiffort et al., 2004) .
The Hh ligand is strongly hydrophobic and hence membraneassociated, which raises critical questions as to how it is secreted and how it can reach cells located at a distance from the signaling cell. Genetic analysis identified Dispatched (Disp) and the Scube family of proteins as being essential for longrange Hh signaling. Disp is a multispanning membrane protein that is required for long-range Hh signaling in Drosophila (Burke et al., 1999) , mouse (Ma et al., 2002) , and zebrafish (Nakano et al., 2004) . Disp belongs to the RND family of transporters (Tseng et al., 1999) and contains a sterol-sensing domain (SSD), a sequence of five consecutive membrane-spanning helices found in several membrane proteins that are involved in cholesterol homeostasis (Kuwabara and Labouesse, 2002) . Disp is specifically required for secretion of cholesterol-modified Hh, as the N-terminal fragment of Hh without the cholesterol modification can be released in the absence of Disp. The Scube family (Grimmond et al., 2000) consists of the secreted proteins Scube1, Scube2, and Scube3, and is required for long-range Hh signaling in zebrafish (Johnson et al., 2012) . Scube2 was first identified in zebrafish (Hollway et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005) as playing a non-cell-autonomous role in long-range Hh signaling. Epistatic analysis led to the proposal that Scube2 is involved in the transport or stability of Hh ligand in the extracellular space (Hollway et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005) .
The mechanism by which the Disp and Scube proteins promote long-range Hh signaling is unknown. Although Disp is required for Hh secretion, there is no direct evidence that Disp participates in Hh release from cells. Additionally, it is unclear how the Hh ligand is kept soluble in the extracellular space, and how it is delivered to responding cells. Regarding Scube proteins, it is unclear whether they are involved in Hh biosynthesis or secretion, or in another aspect of Hh function outside the producing cell.
Here we dissect the mechanism of Hh secretion in vertebrate cells. We show that the vertebrate homolog, Dispatched-A (DispA), interacts with human Sonic hedgehog (hShh) via its cholesterol anchor, and that this interaction is necessary for hShh secretion. Of interest, an inactive DispA mutant binds hShh more strongly than wild-type (WT) DispA, suggesting that dissociation of hShh from DispA is important for efficient secretion. However, DispA alone is not sufficient to release hShh from cells, indicating that additional factors are required to overcome the insolubility conferred by cholesterol modification. We demonstrate that a Scube family member, Scube2, synergizes with DispA to cause a dramatic increase in hShh secretion. Scube2 binds the cholesterol anchor of hShh, and this interaction is necessary to promote hShh secretion. Cholesterol modification is sufficient for a heterologous protein to bind Scube2 and to be secreted in a Scube2-dependent manner. Importantly, DispA and Scube2 recognize different aspects of the cholesterol anchor of hShh. Our results support a model in which membrane-associated hShh is secreted by being handed off from DispA to Scube2, in a manner reminiscent of the transport of free cholesterol by the Niemann-Pick disease proteins NPC1 and NPC2 (Infante et al., 2008b) . Thus, a relay mechanism involving DispA and Scube2 promotes the release of cholesterolmodified hShh from the plasma membrane of producing cells.
RESULTS

DispA Interacts with hShh in a Cholesterol-Dependent Manner
It was previously suggested that Disp may bind cholesterolmodified Hh (Burke et al., 1999) ; however, such an interaction has not been demonstrated. We first tested whether mouse DispA binds cholesterol-modified hShh by coimmunoprecipitation. DispA and hShh were stably coexpressed in 293T cells, followed by detergent solubilization and immunoprecipitation. Under these conditions, WT DispA showed modest but reproducible binding to cholesterol-modified hShh ( Figure 1A) , consistent with the expectation of a transient DispA-hShh interaction. To probe the cholesterol dependence of the interaction, we expressed a construct that encodes the N-terminal fragment of hShh (hShhN, amino acids 1-198), which generates a protein that lacks cholesterol but is still palmitylated (Chamoun et al., 2001; Chen et al., 2004) . DispA did not bind hShhN ( Figure 1A ), indicating that binding to hShh is cholesterol dependent. Of interest, the inactive DispA mutant, DispA-NNN (Ma et al., 2002) , showed significantly stronger hShh binding compared with WT DispA ( Figure 1A ), and the same result was obtained with the inactive mutant, DispA-AAA. DispA-NNN and DispA-AAA are triple-point mutants in which three aspartate residues located in transmembrane helices 4 and 10 are mutated to asparagines or alanines. One of these aspartates is conserved in RND family proteins and is required for their transporter function. Our results suggest that DispA-NNN and DispA-AAA are defective in hShh secretion, perhaps because they bind hShh too tightly and thus interfere with its release from cells.
A potential problem with our binding assay is that detergent solubilization could have a negative effect on the native conformation of DispA and/or might disrupt the DispA-hShh interaction. Therefore, we developed a strategy to examine the DispA-hShh interaction in intact cells using two different photoreactive cholesterol derivatives: (1) 6-azicholestanol (compound 1 in Figure 1B ), a photoreactive sterol that carries a diazirine group on the B ring of the molecule (Thiele et al., 2000) , and (2) 25-azicholesterol (compound 2 in Figure 1B ), a photoreactive sterol that we synthesized, which carries a diazirine group at the end of the isooctyl tail. We reasoned that having the photoreactive group in two locations of the sterol molecule would increase our chance of detecting a potential interaction with DispA. We first asked whether the two photoreactive sterols modify hShh in cells. When cells stably expressing hShh (Chen et al., 2011) were depleted of sterols by acute treatment with methyl-b-cyclodextrin (MCD), hShh processing was strongly inhibited, causing accumulation of the unprocessed hShh precursor ( Figure 1C ). Processing was rescued by adding back cholesterol (compound 3 in Figure 1B ) but not the diastereomer epicholesterol (compound 4 in Figure 1B ), which is inactive in modifying Hh proteins (Mann and Beachy, 2004) . Adding back either of the two photoreactive sterols fully rescued hShh processing ( Figure 1C ). We next used this strategy to generate hShh modified with photoreactive sterols by labeling cells that stably express DispA and hShh. The cells were then UV-irradiated, and the formation of a covalent DispA-hShh bond was tested by denaturing immunoprecipitation of DispA followed by immunoblotting for hShh. DispA showed crosslinking to hShh modified with photoreactive sterol ( Figure 1D ), but not to hShhN, demonstrating that DispA binds hShh in a cholesterol-dependent manner in intact cells. Of interest, DispA was photocrosslinked much more efficiently when hShh was modified with 25-azicholesterol than when it was modified with 6-azicholestanol ( Figures 1D and 1F ), suggesting that the isooctyl tail of cholesterol is a feature recognized by DispA during its interaction with hShh. Consistent with a DispA-hShh interaction in cells, DispA (both the WT and the NNN mutant) and hShh were shown to be present at the plasma membrane by immunofluorescence microscopy ( Figure 1E ). Importantly, not all hShh puncta colocalize with DispA at the membrane, as expected from a transient interaction between the two proteins. In contrast to hShh, hShhN is found predominantly in intracellular vesicles and not at the plasma membrane ( Figure 1E ), consistent with the efficient release of hShhN from the cell surface.
We next asked whether binding of DispA to hShh is important for hShh secretion. To generate a DispA mutant that cannot bind hShh, we deleted the first extracellular loop of DispA. This choice was based on the role that the first extracellular loop plays in two Disp-related proteins: it is required in the SREBP cleavageactivating protein (SCAP) for binding cholesterol (Motamed et al., 2011) , and in Ptch for binding hShh (Marigo et al., 1996) . Indeed, DispA-Dloop1 did not bind hShh in our in vivo photocrosslinking assay ( Figure 1F ). We turned to a cellular assay that relies on the function of DispA in hShh secretion and long-range signaling. DispAÀ/À mouse embryonic fibroblasts (MEFs) (Ma et al., 2002) were cocultured with the Hh reporter cells, Shh Light II (Taipale et al., 2000) . Stable expression of hShh in DispAÀ/À MEFs caused a slight activation of the Hh pathway in the reporter cells ( Figure 1G ) because short-range Hh signaling does not require DispA. Coexpression of mCherrytagged DispA in DispAÀ/À MEFs strongly increased the response of reporter cells, indicating that DispA rescued hShh secretion ( Figure 1G ). As expected, DispA did not affect signaling by DispAÀ/À MEFs expressing hShhN ( Figure 1G ), because DispA is only required for secretion of cholesterolmodified hShh. Similar results were obtained by overexpressing DispA in NIH 3T3 cells ( Figure S1 ). In contrast to WT DispA, mCherry-tagged DispA-Dloop1 or DispA-NNN did not rescue signaling by DispAÀ/À MEFs expressing hShh, a result that is more obvious at a lower ratio of signaling cells to reporter cells ( Figure 1H ). The fact that DispA-Dloop1 is inactive suggests that cholesterol-dependent binding of hShh to DispA is required for hShh secretion.
DispA Is Not Sufficient to Release Cholesterol-Modified hShh from Cells Although the coculture system provides a good functional assay for DispA, it measures hShh secretion only indirectly. To test directly whether DispA is sufficient for hShh release from membranes, we examined secretion of hShh from 293T cells that stably overexpress DispA. Because we observed that serum releases hShh in a nonspecific, DispA-independent manner, we took care to remove residual serum from the cells by repeated washes with serum-free medium. Under serum-free conditions, no hShh was released into the medium, in the absence or presence of overexpressed DispA, as assayed by western blotting (Figure 2A ) or by Hh activity assays ( Figure 2B ). These cells expressed large amounts of hShh, which was properly processed ( Figure 2A ) and strongly localized to the plasma membrane as determined by immunofluorescence microscopy. In contrast, stably expressed hShhN was efficiently secreted into serumfree medium and was active. As expected, DispA had no effect on hShhN secretion (Figures 2A and 2B) . These results indicate that DispA alone is not sufficient to release hShh, perhaps because another factor is required to solubilize it in the media, and in the absence of such a factor, hShh remains membraneassociated.
Cholesterol Is the Main Determinant of hShh Membrane Association
Given that hShhN is efficiently secreted, we tested whether the cholesterol anchor is responsible for the strong association of hShh with membranes. HShh was quickly released from cells when media were supplemented with MCD ( Figure 2C ), which can be explained by MCD binding the cholesterol anchor and promoting hShh solubilization. In contrast to hShh, secretion of hShhN was not further enhanced by MCD ( Figure 2C ).
We next asked whether the other hydrophobic modification of hShh, palmitylation, plays a role in hShh's association with membranes. Like WT hShh, hShh-C24S, a mutant of hShh that cannot be palmitylated but is still modified with cholesterol (Chamoun et al., 2001) , was membrane-associated and was not secreted into serum-free medium ( Figure 2D ). As expected, hShhN and hShhN-C24S, a mutant that lacks both the cholesteryl and palmityl moieties, were efficiently secreted ( Figure 2D ).
Finally, we asked whether cholesterol modification of an unrelated soluble protein is sufficient to recapitulate the strong membrane attachment of hShh. We used a construct encoding a secreted version of the Halotag protein fused to the C-terminal domain of hShh (Halotag-Chh). In cells, this fusion undergoes autocatalytic processing to generate cholesterolmodified Halotag. Hemagglutinin (HA)-tagged Halotag-Chh was expressed in 293T cells, and secretion into serum-free medium was measured by immunoblotting with HA antibodies. Under these conditions, cholesterol-modified Halotag was not secreted and remained membrane-associated ( Figure 2E ); in contrast, Halotag without the cholesterol modification was soluble ( Figure 2E ).
Together, these results indicate that the cholesterol anchor is necessary and sufficient for hShh membrane attachment, and the palmityl moiety plays a less important role, if any. Thus, in order to secrete hShh, cells must find a way to solubilize its cholesterol anchor.
Scube2 Dramatically Increases Secretion of Cholesterol-Modified hShh
The experiments described above suggest the existence of an extracellular protein that helps the secretion of hShh by Figure 1 . Cholesterol-Dependent Binding of hShh to DispA Is Required for hShh Secretion (A) 293T cells stably coexpressing hShh or hShhN, and myc-tagged WT DispA (WT) or DispA-NNN (NNN) were lysed with detergent and analyzed by immunoprecipitation with anti-myc antibodies, followed by SDS-PAGE and immunoblotting with anti-hShh antibodies. (B) Structures of the photoreactive sterols 6-azicholestanol (1) and 25-azicholesterol (2). Also shown are the structures of cholesterol (3) and the inactive diastereomer, epicholesterol (4). (C) HShh, HA-tagged at the C terminus (hShh-HA) was stably expressed in 293T cells. The cells were sterol-depleted with MCD, after which cholesterol (Chol), epicholesterol (epiChol), 6-azicholestanol (6-azi), or 25-azicholesterol (25-azi) was added back as a soluble MCD complex for 3 hr. Lysates were analyzed by SDS-PAGE and immunoblotting with HA antibodies (to detect the hShh precursor and the C-terminal fragment, hShhC) and hShh antibodies (to detect the hShh ligand). (D) 293T cells stably coexpressing myc-tagged DispA-WT and hShh or hShhN were labeled with the indicated sterols, as in (B). After incubation for 6 hr, the cells were UV-irradiated, and DispA-hShh photocrosslinking was analyzed by denaturing immunoprecipitation with myc antibodies, followed by SDS-PAGE and immunoblotting for hShh. Immunoblotting for tubulin served as the loading control. (E) Left panels: Immunofluorescence microscopy of hShh stably coexpressed with myc-tagged DispA-WT or DispA-NNN in NIH 3T3 cells. Cells were stained with rabbit anti-hShh and mouse anti-myc antibodies, followed by goat anti-rabbit Alexa488 and goat anti-mouse Alexa594 secondary antibodies. Right panels: Localization by immunofluorescence microscopy of hShh and hShhN expressed in DispAÀ/À MEFs. (F) As in (C) but with 293T cells stably coexpressing myc-tagged DispA or the mutant missing the first extracellular loop, DispA-Dloop1 (D), together with hShh or hShhN. (G) DispAÀ/À MEFs stably expressing hShh or hShhN, rescued by lentiviral expression of mCherry-tagged DispA or not, were cocultured with Hh-responsive Shh Light II cells at a 1:20 ratio. Luciferase measurements were normalized to reporter cells grown alone (control). All experiments were performed in triplicate. Error bars represent the SD of the mean. (H) DispAÀ/À MEFs stably expressing hShh, transduced with lentiviruses expressing mCherry-tagged DispA-WT, DispA-Dloop1, or DispA-NNN were analyzed as in (G), at four different ratios of hShh-producing cells to reporter cells. See also Figure S1 . overcoming its cholesterol-dependent insolubility. The Scube family of secreted proteins is required for long-range Hh signaling in zebrafish (Johnson et al., 2012) , but its mechanism is unknown. We examined whether the first Scube protein implicated in Hh signaling, Scube2 (Hollway et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005) , is involved in releasing hShh from cells. When Scube2 was expressed in 293T cells stably expressing hShh, it caused a dramatic increase in secretion of active hShh ( Figure 3A) . As a negative control, we used Scube2DCUB, a truncation mutant of Scube2 that lacks a C-terminal portion of the protein, including a cysteine-rich domain and a CUB domain. This loss-of-function mutation was identified in the initial cloning of zebrafish Scube2 (Woods and Talbot, 2005) . Scube2DCUB was efficiently secreted but failed to stimulate hShh secretion (Figure 3A) . Scube2 supplied exogenously also released hShh into serum-free media, indicating that Scube2 and hShh do not have to be coexpressed ( Figure 3B ). Scube2 had no effect on the secretion of hShhN, indicating that it acts specifically to release cholesterol-modified hShh ( Figure 3C ). Of interest, although the amount of released hShh was significantly smaller than that of hShhN, the signaling activity of hShh was much higher than that of hShhN ( Figure 3C ), suggesting that cholesterol modification greatly enhances the potency of the hShh ligand.
It is known that hShh can be released from cells by serum (Chen et al., 2011) and by high levels of heparin. HShh released with either serum or heparin was inactive in signaling assays, in contrast to hShh released by Scube2 ( Figure S2 ). Thus, unlike other factors that can release hShh, release by Scube2 is physiological.
All Scube2 orthologs contain a conserved hydrophobic stretch in the middle of the CUB domain ( Figure 3D ), whereas the rest of the protein shows little clustering of hydrophobic amino acids outside the signal sequence. We reasoned that this hydrophobic stretch might be important for release of hShh. Indeed, a Scube2 mutant in which eight amino acid residues in the hydrophobic stretch are mutated to alanines (Scube2-8Ala) is secreted ( Figure 3E ) but is completely inactive in releasing hShh ( Figures 3E and 3F ). This indicates that the conserved hydrophobic sequence in the CUB domain is necessary for Scube2 activity.
We next asked whether palmitylation of hShh is required for release by Scube2. Like WT hShh, the nonpalmitylated mutant hShh-C24S was released by Scube2 but not by Scube2DCUB ( Figure 3G ), indicating that palmitylation is not required for Scube-mediated hShh secretion. The Scube2-released hShh-C24S was inactive in Hh signaling assays ( Figure 3H ), consistent with the requirement of the palmityl modification for Hh activity (Chamoun et al., 2001) . We also performed an experiment to determine the effect of temperature on the release of hShh from cells by Scube2. Although the added Scube2 released a significant amount of hShh during 1 hr at 37 C, no hShh was released at 4 C ( Figure 3I ). This is consistent with Scube2 having to overcome the hydrophobic interaction between the cholesterol anchor of hShh and the membrane, an interaction of increased strength at lower temperature.
Scube2 Does Not Affect hShh Processing in Producing Cells or Signaling in Responding Cells One possible explanation for the enhanced secretion of hShh is that Scube2 stimulates hShh processing in producing cells. A radioactive pulse-chase analysis of hShh processing showed that it proceeded with the same kinetics in the presence of coexpressed Scube2 or the inactive Scube2DCUB mutant ( Figure 4A ). This result indicates that Scube2 does not affect hShh processing.
To determine whether Scube2 has an effect on Hh signal transduction, we performed two experiments. First, we asked whether Scube2 affects signaling by hShhN. Increasing concentrations of Scube2 added to a fixed concentration of hShhN had no effect on Hh pathway stimulation ( Figure 4B , left side of the graph). In a second experiment, we asked whether excess Scube2 affects signaling by hShh. When increasing amounts of Scube2 were added to hShh released into Scube2-containing media, there was no effect on Hh pathway stimulation ( Figure 4B , right side of the graph); furthermore, Scube2 had no effect on Hh signaling on its own. Although it was previously proposed that Scube2 promotes Hh signaling at the level of the responding cell, possibly via its interaction with Ptch (Tsai et al., 2009 ), our Scube2 titration experiment argues against such a model. Our data, however, cannot exclude the possibility that the hShh-Scube2 complex (see below) is the active species in long-range Hh signaling.
Scube2 Binds hShh in a Cholesterol-Dependent Manner
It seemed likely that Scube2 might stimulate hShh secretion by direct binding. We first tested this hypothesis by immunoprecipitation of hShh secreted into serum-free medium by cells coexpressing hShh and HA-tagged Scube2, followed by immunoblotting for HA. Under these conditions, we detected binding of Scube2 to hShh ( Figure 4C ). Scube2 did not bind hShhN, indicating that Scube2 binds hShh in a cholesteroldependent manner ( Figure 4C ). As expected, the inactive mutant Scube2DCUB did not release or bind hShh, suggesting that binding to Scube2 is required for hShh secretion.
In the above experiment, hShh was immunoprecipitated with the 5E1 monoclonal antibody, which blocks binding of hShh to Ptch and to the antagonist Hedgehog-interacting protein (HIP), due to the very similar binding interfaces between hShh and 5E1, HIP, and Ptch (Maun et al., 2010) . In contrast, the 5E1 antibody did not block binding of hShh to Scube2, indicating that the hShh-Scube2 interface is distinct, and thus hShh binding to Scube2 might allow hShh interaction with the downstream components Ptch and HIP.
Finally, we examined the interaction between Scube2 and hShh in cells by photocrosslinking. Cells stably expressing HA-tagged Scube2 and hShh were labeled with photoreactive sterols and then UV-irradiated. Lysates were subjected to denaturing immunoprecipitation with HA antibodies, followed by immunoblotting for hShh. We detected crosslinking between hShh modified with 6-azicholestanol and Scube2; as expected, Scube2DCUB was not crosslinked to Scube2 ( Figure 4D ). Interestingly, hShh modified with 25-azicholesterol showed much less crosslinking to Scube2 (Figure 4D) , in contrast to DispA-hShh crosslinking, which occurred preferentially with 25-azicholesterol. This differential crosslinking suggests that Scube2 and DispA recognize different structural aspects of the cholesterol molecule, in a manner that might facilitate the hand-off of hShh from DispA to Scube2.
DispA Synergizes with Scube2 to Promote hShh Secretion
We next tested whether DispA and Scube2 act synergistically to promote hShh secretion, first in the coculture system of DispAÀ/À MEFs and Hh reporter cells. DispAÀ/À MEFs expressing hShh and DispA were plated at different ratios with Hh reporter cells, and the cocultures were incubated with Scube2 in serumfree media, followed by Hh activity assays. Under these conditions, Scube2 strongly synergized with WT DispA to cause hShh secretion and Hh pathway activation ( Figure 5A ). As expected, Scube2 did not synergize with DispA-NNN and had no effect on signaling by hShhN; also, Scube2DCUB had no effect on hShh ( Figure 5A) . Interestingly, at a higher ratio of hShh-producing cells to reporter cells, Scube2 was able to release some hShh even in the absence of DispA ( Figure 5A) , consistent with a model in which hShh partitions between the membrane and Scube2 in the media.
Similar results were obtained when we measured hShh secretion in 293T cells in the absence and presence of coexpressed myc-tagged DispA. Addition of Scube2 to the cells synergized with WT DispA to release hShh into the supernatant, as assayed by immunoblotting ( Figure 5B ). As expected, Scube2 did not synergize with DispA-NNN, and Scube2DCUB had no effect on hShh secretion, irrespective of the presence of DispA ( Figure 5B) . Similarly, Scube2 added to 293T cells synergized with DispA (but not with DispA-Dloop1) to cause secretion of hShh, as measured by Hh reporter assays ( Figure 5C ). Together, these data show that DispA and Scube2 act synergistically to promote hShh secretion.
Cholesterol Modification Is Sufficient for Interaction with Scube2 and Scube2-Dependent Secretion
We sought to determine whether cholesterol modification is sufficient for interaction with Scube2, by photocrosslinking in vitro. To that end, we used an unrelated protein [maltosebinding protein (MBP)] that we modified with photoreactive sterols by in vitro processing (Chen et al., 2011;  Figure 6A ). We then incubated sterol-modified MBP fusions with HA-tagged Scube2, followed by UV irradiation and immunoblotting with HA antibodies, to detect an increase in Scube2 size due to photocrosslinking. Under these conditions, Scube2 was crosslinked to MBP modified with 6-azicholestanol ( Figure 6B) , and much less efficiently to MBP modified with 25-azicholesterol. This is the same preference for 6-azicholestanol over 25-azicholesterol that we observed for hShh-Scube2 photocrosslinking in Figure 3 . The Extracellular Protein Scube2 Stimulates Secretion of Cholesterol-Modified hShh (A) Scube2 or Scube2DCUB was transfected into 293T cells stably expressing hShh, and 24 hr later secreted proteins were collected into serum-free media for 4 hr. HShh activity in serial dilutions of the supernatant was measured by luciferase assay in Shh Light II reporter cells. All experiments were performed in triplicate. Error bars represent the SD of the mean. (B) Scube2 or Scube2DCUB was added in serum-free media to 293T cells stably expressing hShh, for 4 hr. Activity of secreted hShh was measured as in (A). (C) As in (A) but with 293T cells stably expressing hShh or hShhN. Secreted hShh and hShhN were collected for 6 hr and analyzed by reporter assay in Shh Light II cells and by immunoblotting with anti-hShh antibodies. Note the much higher amount of secreted hShhN compared with hShh. cells ( Figure 4D ). The size of the electrophoretic mobility shift in Scube2 crosslinked to MBP ( Figure 6B) is consistent with the addition of one molecule of MBP (40 kDa), indicating a 1:1 binding ratio between Scube2 and sterol-modified MBP. As expected, Scube2DCUB was not crosslinked to any of the sterol-modified MBP proteins. These results suggest that cholesterol modification is sufficient for binding to Scube2.
Finally, we investigated whether cholesterol modification is sufficient for Scube2-dependent secretion. For this purpose, we used cholesterol-modified Halotag, which is membraneassociated ( Figure 2E ). HA-tagged Halotag-Chh was coexpressed in 293T cells with myc-tagged Scube2, and secretion into serum-free medium was measured by immunoblotting. As shown in Figure 6C , cholesterol-modified Halotag was secreted only in the presence of Scube2, whereas Halotag without a cholesterol anchor was secreted independently of Scube2.
As expected, Scube2DCUB did not release cholesterol-modified Halotag. These data demonstrate that a cholesterol anchor is sufficient for an unrelated soluble protein to become membrane-associated, to bind Scube2, and to be secreted in a Scube2-dependent manner.
DISCUSSION
This study suggests a mechanism whereby hShh is released from cells in spite of its strong association with membranes. HShh has two lipid modifications: a palmityl residue at the N terminus and a cholesteryl residue at the C terminus. The cholesteryl moiety is mainly responsible for the insolubility of hShh, which has to be overcome to allow hShh mobilization and long-range Hh signaling. We now show that the multispanning membrane protein DispA and the secreted protein Scube2 (D) Sequence of the conserved hydrophobic patch in the CUB domain of vertebrate Scube2 orthologs. Also shown is the sequence of the Scube2-8Ala mutant, in which eight hydrophobic residues are mutated to alanines. (E) HA-tagged Scube2, Scube2-8Ala, or Scube2DCUB was transfected into 293T cells stably expressing hShh, and 24 hr later the secreted proteins were collected for 6 hr into serum-free media. Aliquots of the cell pellet and supernatants were analyzed by SDS-PAGE and immunoblotting for HA and hShh. (F) HShh activity in the supernatants collected in (E) was measured as in (A). (G) HShh or the palmitylation-defective mutant hShh-C24S were coexpressed in 293T cells with HA-tagged Scube2 or Scube2DCUB. HShh and hShh-C24S secretion was analyzed as in (E). (H) HShh and hShh-C24S activity in the supernatants collected in (G) was measured as in (A). (I) Scube2 or Scube2DCUB was added in serum-free medium to 293T cells stably expressing hShh, for 1 hr at 37 C or 4 C. HShh activity in the supernatants was measured as in (A). See also Figure S2 . The cells were pulsed with 35 S-methionine for 3 min and chased with media containing unlabeled methionine for the indicated times. HShh processing was analyzed by immunoprecipitation with the 5E1 antibody, which recognizes fulllength and processed hShh. Scube2 and Scu-be2DCUB were immunoprecipitated with anti-HA antibodies. The precipitated protein was analyzed by SDS-PAGE and fluorography. The same number of cells was processed for each condition. (B) The two graphs on the left show that Scube2 does not affect hShhN activity. hShhN was mixed with HA-tagged Scube2 or Scube2DCUB, at the indicated ratios, and its activity was measured in Shh Light II reporter cells. The two graphs on the right show that Scube2 does not affect the activity of hShh prereleased with Scube2. 293T cells coexpressing hShh and HA-tagged Scube2 were used to generate serum-free hShh-Scube2 conditioned media. This media was mixed with HA-tagged Scube2 or Scube2DCUB, at the indicated ratios, and its activity was measured in Shh Light II reporter cells. All experiments were performed in triplicate. Error bars represent the SD of the mean. (C) 293T cells coexpressing hShh or hShhN, and HA-tagged Scube2 or Scube2DCUB were incubated in serum-free media for 4 hr. HShh and hShhN were immunoprecipitated from the supernatant with 5E1 antibodies. A portion of the supernatant was TCA-precipitated to serve as input. All samples were analyzed by SDS-PAGE and immunoblotting with anti-HA and anti-hShh antibodies. (D) HShh or hShhN was stably coexpressed with HA-tagged Scube2 or Scube2DCUB in 293T cells. The cells were labeled with the indicated sterols, followed by UV irradiation. Photocrosslinked Scube2-hShh was analyzed by denaturing immunoprecipitation with HA antibodies, followed by SDS-PAGE and immunoblotting for hShh. cooperate to accomplish hShh secretion. We demonstrate that during secretion, hShh uses its unique cholesterol modification to interact with DispA and Scube2 via two distinct and synergistic binding events, and that these two interactions are required for hShh secretion. Interestingly, DispA and Scube2 recognize different structural aspects of the cholesterol molecule ( Figure 7A ), suggesting a hand-off mechanism for transferring hShh from DispA to Scube2. The advantage of such a mechanism is that it ensures that hShh is never free in the aqueous environment, thus preventing its precipitation. According to this model, DispA would act in the hShh-synthesizing cell, whereas Scube2 could be provided either by the producing cell or by another cell.
Our results are in agreement with previous genetic evidence that showed that long-range Hh signaling absolutely requires Disp in vertebrates (Ma et al., 2002; Nakano et al., 2004) and in insects (Burke et al., 1999) , and the Scube family of secreted proteins in zebrafish (Hollway et al., 2006; Johnson et al., 2012; Kawakami et al., 2005; Woods and Talbot, 2005) . Both Disp and Scube are not required for short-range Hh signaling, consistent with their demonstrated role in hShh secretion rather than signal transduction. In addition, consistent with our results, a genetic analysis showed that Scube2 acts Light II reporter cells at 1:40 and 1:80 ratios. After 12 hr, Scube2 or Scu-be2DCUB was added in serum-free media. Luciferase measurements were performed 30 hr later and normalized to untreated reporter cells. All experiments were done in triplicate. Error bars represent the SD of the mean. (B) HA-tagged Scube2 or Scube2DCUB was transfected into 293T cells that stably express hShh, hShh, and myc-tagged DispA-WT, or hShh and myc-tagged DispA-NNN. Secreted proteins were collected 24 hr later into serum-free media for 4 hr. Aliquots of the cellular pellets and supernatants were analyzed by SDS-PAGE and immunoblotting with HA, myc, and hShh antibodies. Blotting for GSK3 served as loading control. (C) Constructs that generate Halotag protein modified with cholesterol (Halotag-Chh) or not (Halotag) were coexpressed in 293T cells with myctagged Scube or Scube2DCUB. Secreted proteins were collected in serumfree media for 6 hr, followed by TCA precipitation and immunoblotting with HA and myc antibodies. non-cell-autonomously, in contrast to Disp. So far, an essential role for Scube proteins in Hh signaling has only been demonstrated in zebrafish (Johnson et al., 2012) , but sequence conservation suggests that the function of Scube is conserved in mammalian Hh signaling.
While this manuscript was under review, Creanga et al. (2012) published a study that showed that Scube2 mediates the release of cholesterol-and palmityl-modified hShh. Both that study and ours agree that cholesterol (but not palmitate) is strictly required for hShh release by Scube2; however, Creanga et al. showed that palmitylation enhances the release of hShh by Scube2, which we did not observe in our experiments. The reason for this discrepancy remains to be elucidated. It should be pointed out that Scube-released hShh that lacks the palmitate modification is completely inactive in signaling assays (Creanga et al., 2012 and this study) .
Our data support the following sequence of events in hShh biosynthesis ( Figure 7B ): Following autocatalytic cholesterol modification in the ER and palmitylation, hShh reaches the plasma membrane, to which it remains strongly attached via its cholesterol anchor. HShh then binds DispA, a cholesteroldependent interaction that lowers the activation energy required for hShh extraction from the bilayer. Alternatively, hShh could associate with DispA earlier in the secretory pathway, and the two proteins could travel together to the plasma membrane. Binding to DispA is necessary but not sufficient for hShh secre- (A) Summary of the results for photocrosslinking of hShh to DispA and to Scube2 in cells. DispA is crosslinked to hShh modified with 25-azicholesterol, and Scube2 is crosslinked to hShh modified with 6-azicholestanol, suggesting that DispA and Scube2 recognize different aspects of the cholesterol molecule. (B) The hShh ligand associates with membranes due to its hydrophobic cholesterol anchor. HShh binds DispA in a cholesterol-dependent manner, and this interaction is required for hShh secretion, perhaps by lowering the activation energy for hShh extraction from the lipid bilayer. From DispA, hShh is transferred to the secreted protein Scube2. The fact that DispA and Scube2 recognize different features of the cholesterol molecule suggests a hand-off mechanism for this transfer, such that the cholesterol anchor of hShh never contacts the aqueous environment directly and is thus kept soluble. This mechanism is reminiscent of the transfer of free cholesterol between the Niemann-Pick disease proteins NPC1 and NPC2 during cholesterol egress from late endosomes/ lysosomes. tion, because an extracellular binding partner is needed for hShh solubility. Additionally, if DispA binding is too strong, hShh secretion is impaired, as seen with some inactive DispA mutants. In the next step, hShh is transferred from DispA to the secreted protein Scube2, which is required for long-range Hh signaling in zebrafish. Scube2 interacts with the cholesterol anchor of hShh and dramatically enhances hShh secretion by promoting its solubility. Cholesterol modification is sufficient, as demonstrated by the fact that an unrelated protein can be secreted in a Scube2-dependent manner. Although it is possible that Scube and Shh associate before reaching the plasma membrane when synthesized in the same cell, it is clear that this is not required for hShh secretion, as exogenous Scube2 can release hShh displayed on the cell surface.
It should be emphasized that the steps in hShh secretion outlined above represent partitioning equilibria of cholesterolmodified hShh, so that high concentrations of Scube2 solubilize hShh from membranes even without DispA (the equilibrium on the left of Figure 7B ). HShh secretion, however, is greatly enhanced by DispA, as demonstrated by the strong synergy we observed between DispA and Scube2. How DispA synergizes with Scube2 remains to be elucidated. One possibility is that the orientation of the cholesterol anchor of hShh in the membrane favors its transfer to DispA, and is less favorable for a direct transfer to Scube2. Alternatively, Scube2 might bind DispA, which could facilitate the transfer of hShh between the two proteins. Based on homology to RND transporters, it was postulated that DispA acts as a pump (Ma et al., 2002) . We speculate that the pumping activity of DispA might be involved in the transfer of hShh to Scube2. It will be important to elucidate the source of energy that DispA uses to pump hShh.
The interaction between Scube2 and hShh is expected to be dynamic, to allow hShh release. Such a transient interaction raises the question of how Scube2 keeps hShh soluble. One model is that hShh is kept soluble by an excess of Scube2, similar to sterol solubilization by complexation with MCD, in which sterol-MCD binding is dynamic and a several-fold molar excess of MCD is usually required for keeping the sterol soluble in aqueous solution. In a more complicated model, Scube2 might chaperone hShh and help it form a soluble multimeric species in which the cholesterol anchors are shielded from the aqueous environment by interactions between hShh monomers. A more detailed biochemical and structural analysis of the hShh-Scube interaction will be needed to answer this question.
Our results suggest that Scube2 is not simply a solubilizing factor. HShh can be released by other agents, such as heparin and serum, but this requires very high concentrations and the released hShh is inactive in signaling assays. Thus, Scube2 interacts with hShh in a specific and efficient manner that maintains hShh activity. This raises the possibility that the hShh-Scube complex is the active species that signals to responding cells. For example, Scube2 might interact with Ptch, a possibility suggested by our finding that the 5E1 antibody, which blocks hShh binding to Ptch, does not block hShh binding to Scube2. Alternatively, Scube2 might interact with one of the hShh coreceptors Gas1, Cdo, and Boc. Any such interaction could facilitate the delivery of hShh to responding cells.
Although cholesterol modification of Hh and the role of Disp are conserved between invertebrates and vertebrates, Scube proteins are only present in vertebrates. How then do invertebrates secrete Hh? A likely possibility is that the role of Scube is fulfilled in invertebrates by another secreted protein or by lipoprotein particles. Lipoproteins have been implicated in systemic transport of Hh in Drosophila (Paná ková et al., 2005) . It is unclear, however, whether lipoproteins are present in the extracellular space of early embryonic tissues, and thus whether they play a role in Hh signaling at that stage. A biochemical approach will be required to determine whether a secreted protein and/or lipoproteins function in invertebrates in a manner similar to that observed for Scube in vertebrates.
The proposed mechanism of hShh secretion is reminiscent of cholesterol trafficking by the Niemann-Pick disease proteins NPC1 and NPC2 (Infante et al., 2008b) , which are involved in the egress of cholesterol from late endosomes/lysosomes. Cholesteryl esters are hydrolyzed in the lumen of the lysosome, releasing free cholesterol that binds NPC2, a soluble luminal cholesterol-binding protein. NPC2 transfers cholesterol to NPC1, a multispanning membrane protein in the limiting membrane of the lysosome. Cholesterol is then released from NPC1 into the lysosomal membrane, followed by its transport to other cellular membranes, perhaps through the cytosolic face of the membrane.
A comparison of hShh secretion with cholesterol egress from lysosomes reveals similarities as well as some important differences. DispA and NPC1 are both members of the RND family of transporters, and DispA binds the cholesterol anchor of hShh as NPC1 binds cholesterol (Infante et al., 2008a) .
Although there is no homology between Scube2 and NPC2, they localize to topologically equivalent spaces (the extracellular space for Scube2 and the lumen of the late endosome/lysosome for NPC2), and Scube2 binds the cholesterol anchor of hShh as NPC2 binds cholesterol (Infante et al., 2008b) . Importantly, DispA and Scube2 recognize different aspects of the cholesterol molecule ( Figure 7A) , which parallels the two distinct binding modes of NPC1 and NPC2 to cholesterol (Kwon et al., 2009 ). However, whereas DispA appears to recognize the isooctyl tail of cholesterol, NPC1 binds cholesterol with the 3b-hydroxy buried and the isooctyl tail exposed (Kwon et al., 2009) . Also, Scube2 appears to not bind the isooctyl tail of cholesterol, whereas NPC2 binds the isooctyl tail (Kwon et al., 2009 ). Finally, one important difference is the direction of transport: DispA and Scube2 move hShh from the membrane to the extracellular space, whereas NPC1 and NPC2 transport cholesterol in reverse, from the lumen of the lysosome into the limiting membrane.
In summary, our results demonstrate a mechanism for hShh secretion that is reminiscent of the egress of free cholesterol from late endosomes/lysosomes. Both processes rely on the recognition of unique aspects of the cholesterol molecule, and in both cases a similar mechanism is used to achieve solubility of the hydrophobic ligand. Because mutations in NPC proteins cause disease, it seems possible that Disp and Scube could be involved in the pathogenesis of Hh signaling defects, such as those that cause holoprosencephaly.
EXPERIMENTAL PROCEDURES
Chemicals
The synthesis of the two photoreactive sterols used in this study is described in the Supplemental Information.
Cell Culture
Details of the cell culture conditions, DNA constructs, immunofluorescence microscopy, pulse-chase assays, immunoprecipitation, and production of Scube2-conditioned media are provided in the Supplemental Information.
To determine whether photoreactive sterols modify hShh in vivo, 293T cells stably expressing hShh-HA (Chen et al., 2011) were sterol-depleted with 1% MCD in Dulbecco's modified Eagle's medium (DMEM) for 45 min. Sterols were then added back as soluble MCD complexes. After 3 hr, the cells were harvested and hShh processing was assayed by immunoblotting.
Photocrosslinking in Cells
Human 293T cells stably expressing myc-tagged DispA and hShh constructs were sterol-depleted, followed by incubation with sterol-MCD complexes (75 mM for cholesterol and 25-azicholesterol, and 25 mM for 6-azicholestanol) in OptiMEM (Invitrogen) for 2 hr. After washing with OptiMEM, the cells were incubated for 6 hr, followed by UV irradiation for 10 min on ice. The cells were harvested and DispA constructs were subjected to denaturing immunoprecipitation with anti-myc antibodies (9E10) followed by SDS-PAGE and immunoblotting with rabbit anti-hShhN antibodies (Cell Signaling). A similar protocol was used to detect interaction of hShh to HA-tagged Scube2 in cells.
Photocrosslinking In Vitro
A fragment of Drosophila Hh comprising amino acids 244-471 was expressed and purified from bacteria as a soluble MBP fusion (Chen et al., 2011 ) and used to generate photoreactive sterol-modified MBP by in vitro processing. Sterol-modified MBP was incubated for 1 hr with HA-tagged Scube2 or Scube2DCUB, followed by UV irradiation for 10 min on ice. The samples were analyzed by SDS-PAGE and immunoblotting with HA antibodies.
Secretion Assays
293T cells stably expressing hShh were washed several times with DMEM to remove serum, and incubated in DMEM with or without the indicated factors. At the indicated time, the culture medium was harvested and secreted protein was analyzed either by precipitation with trichloroacetic acid (TCA) followed by SDS-PAGE and immunoblotting, or by Hh reporter assays.
Reporter Assays
Hh activity was assayed in Shh Light II cells (Taipale et al., 2000) . After incubation for 30 hr, firefly luciferase (expressed under control of a Hh-responsive promoter) and Renilla luciferase (expressed under control of a constitutive promoter) were measured using the Dual-Glo kit (Promega). Hh pathway activity was calculated as the firefly/Renilla ratio, normalized to one for unstimulated cells. Each experiment was performed in triplicate, and error bars represent the SD of the mean. For coculture assays, 293T cells or DispAÀ/À MEFs expressing various hShh, DispA, and Scube2 constructs were plated together with Shh Light II cells. After 12 hr, the serum was washed off and the cells were incubated for 30 hr in serum-free media, followed by luciferase reporter assays.
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